Clinical Trials Logo

Filter by:
NCT ID: NCT04691713 Recruiting - Solid Tumor Clinical Trials

CD276 CAR-T for Patients With Advanced CD276+ Solid Tumors

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

This study is a clinical study of CD276 CAR-T in the treatment of patients with advanced solid tumors. The purpose is to evaluate the safety and effectiveness of targeting CD276 auto-chimeric antigen receptor T cells in the treatment of CD276-positive advanced solid tumors.

NCT ID: NCT04691453 Recruiting - Clinical trials for Uterine Cervical Neoplasms

QM-B and QM-C Hysterectomy for Early Cervical Cancer

QMBCHECC
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The goal of this clinical research study is to compare the long-term outcomes and safety of Querleu-Morrow-B(QM-B) and Querleu-Morrow-C(QM-C) hysterectomy for early cervical cancer. In this study, the surgical approach for QM-B and QM-C hysterectomy will be abdominal.

NCT ID: NCT04691388 Recruiting - NSCLC Clinical Trials

The Efficacy and Safety of Antinib Hydrochloride Combined With Sindilumab in Advanced NSCLC Patients

Start date: December 1, 2020
Phase: Phase 2
Study type: Interventional

The combination of immunocheckpoint inhibitors and anti-angiogenesis therapy has synergistic anti-tumor effect and is a reasonable method to improve the prognosis of patients. Therefore, in this study, it is hoped that antinib hydrochloride combined with Sinidilizumab can overcome immunotherapy resistance, improve the efficacy of immunotherapy, and further improve the survival of patients, so as to provide more clinical evidence for the treatment of advanced NSCLC patients with negative driver gene after first-line treatment with anti-PD-1 antibody.

NCT ID: NCT04691349 Recruiting - Child, Only Clinical Trials

CAR-T for r/r Malignant Tumors in Children

Start date: September 27, 2020
Phase: Early Phase 1
Study type: Interventional

This study is a clinical study of CAR-T treatment of patients with relapsed/refractory malignant tumors in children. The purpose is to evaluate the safety and effectiveness of chimeric antigen receptor T cells in the treatment of relapsed/refractory malignant tumors in children.

NCT ID: NCT04691271 Recruiting - Clinical trials for Aneurysmal Subarachnoid Hemorrhage

Stellate Ganglion Block and Cerebral Vasospasm

BLOCK-CVS
Start date: July 1, 2021
Phase: N/A
Study type: Interventional

At present, cerebral vasospasm (cVS) is the main cause of delayed cerebral infarction (DCI), which leads to high disability and mortality rate after aneurysmal subarachnoid hemorrhage. As a consequence, the key of reducing DCI is to prevent cVS. But unfortunately, despite years of efforts, the prevention and treatment of cVS is still a major clinical dilemma and various ways of treatment are still being explored. Recent studies have shown that stellate ganglion block (SGB) can dilate cerebral vessels and alleviate the impact of existing cVS. However, there is no study to evaluate the effect of early application of SGB on the improvement and prevention of cVS after aSAH.

NCT ID: NCT04691076 Recruiting - Pain Clinical Trials

Effect of Low-dose Esketamine Combined With Target-controlled Infusion of Propofol for Painless Gastrointestinal Endoscopy

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

Purpose: 1. To determine the efficacy of low-dose esketamine in painless gastrointestinal endoscopy. 2. To determine the safety of low-dose esketamine in painless gastrointestinal endoscopy. 3. To provide a theoretical basis and new ideas for the application of esketamine as a new drug in perioperative period.

NCT ID: NCT04691037 Recruiting - Clinical trials for Coronary Artery Disease

CCTA Improves Clinical Management of Stable Chest Pain

CICM-SCP
Start date: January 1, 2016
Phase:
Study type: Observational [Patient Registry]

The investigator aims to prospectively enroll patients who were referred for coronary computed tomography angiography (CCTA) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent CCTA according to established guidelines and local institutional protocols. The imaging data were evaluated using different image post-processing software to comprehensively analyse anatomical, functional and histological information of coronary. This study will determine if CCTA-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.

NCT ID: NCT04690478 Recruiting - Hypertension Clinical Trials

Remote Blood Pressure Management Clinical Application Research

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Recruit patients with essential hypertension and randomly divide them into three groups. For 24 months, observe the patient's blood pressure level and blood pressure compliance rate,Risk assessment, etc.

NCT ID: NCT04690075 Recruiting - Chronic Disease Clinical Trials

Effect of Dietary Fiber on Metabolism, Inflammation and Nutritional Status in Patients With Chronic Diseases

Start date: December 24, 2020
Phase: N/A
Study type: Interventional

The prevalence of chronic disease is increasing rapidly in China. Medical nutritional therapy (MNT) is essential for the prevention and control of chronic diseases. For example, dietary fiber plays an important role in chronic disease management. Evidence suggests that increasing fiber intake can decrease the risk of chronic diseases, such as overweight/obesity, hyperlipidemia, hyperglycemia, GI diseases, etc. However, according to the nation-wide survey, the dietary fiber intake of Chinese people shows a downward trend in recent years, and the relationship between dietary fiber and metabolism of chronic patients is still controversial. So, this study aims to explore the effects of dietary fiber on metabolism, inflammatory factors and nutritional status among patients with chronic diseases, so as to provide reference for proper nutrition intervention towards chronic disease.

NCT ID: NCT04689893 Recruiting - Clinical trials for Tumor-Induced Osteomalacia

Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO

Start date: March 15, 2020
Phase: Phase 1
Study type: Interventional

This is an open-label whole-body PET/CT study for investigating the value of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in patients with Tumor-induced osteomalacia.